TRADING QUOTES 10:22 PM July 17, 2024
[stock-market-overview stockExchange="NYSENasdaq" width="600px" title="Brookline Capital Acquisition Corporation *" equities="APGN;APGNW" allowSort="true" includeChart="true" logoMaxHeight="20px" logoMaxWidth="90px" height="100%" culture="English-US"]
IPO Terms Details Business Combination Related Articles SEC Filings
SPAC Name : Brookline Capital Acquisition Corporation *
Total Public Proceeds at IPO($mm): 57.5
%Held in Trust: 101.0
$Held in Trust per Unit: $ 10.10
Mgmt's Sector Expertise/Focus: BioTech
IPO Date: 2021-01-29
Months to Complete: 15
Deadline Date: 2022-08-02
Unit Structure (BCACU)
Share (BCAC): 1 Share of Common Stock
Warrant (BCACW) 1/2 Warrant
Right() None
Public Warrant Terms:
Exercise Price: 11.500000000
Redemption Price: Cash/Cashless: $18.00
Redemption: Cash, Cashless or for Shares Mgmt's Discretion
Underwriters:
Book-runner(s): Ladenburg Thalmann
Co-Manager(s):
Fees (Upfront/Deferred): 1.5%/---
Lawyers:
Issuer's Counsel: Ellenoff Grossman & Schole LLP
Underwriter's Counsel: Graubard Miller
Additional Terms: Crescent Term: $9.20 threshold, Limitation on redemption rights: 15%
SPAC Name: Brookline Capital Acquisition Corporation *
CURRENT FUNDS in TRUST: $0*
EST. PRO RATA AMOUNT IN TRUST: $10.22*
IMPLIED ENTERPRISE VALUE: $151.9 million
RECORD DATE: 2022-06-27
SHAREHOLDER VOTE DATE: 2022-07-27
SPAC NameSource: SEC.gov filings and SPAC Insider estimates

TRADING QUOTES       Business CombinationIPO Terms Details SPAC name: %spacname% CURRENT FUNDS in TRUST: $%ending_trust_ball%* EST. PRO RATA AMOUNT IN TRUST: $%implied_cash_per_share%* IMPLIED ENTERPRISE VALUE: %impliedenterprisevalue% RECORD DATE: %businesscombinationrecorddate% SHAREHOLDER VOTE DATE: %businesscombinationshareholdervotedate% Source: SEC.gov filings and SPAC Insider estimates SPAC name: %spacname% Total Public Proceeds at IPO ($mm): %total% % Held in Trust:
Read More

To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.